Baranov V

No ORCID on file · 5 papers in corpus · active 1997-2023

Study types

  • article 2

Condition tags

  • endometriosis 2
article 2023
iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
Pharmaceutics ·doi:10.3390/pharmaceutics15082108

Anti-angiogenic RNAi-based therapy can be considered as a possible strategy for the treatment of endometriosis (EM), which is the most common gynecological disease. Targeted delivery of siRNA therapeutics is a prerequisite for successful tr…

2022
Magnetic Nanoparticles as a Component of Peptide-Based DNA Delivery System for Suicide Gene Therapy of Uterine Leiomyoma.
Bioengineering (Basel, Switzerland) ·doi:10.3390/bioengineering9030112

Suicidegene therapy is considered a promising approach for the treatment of uterine leiomyoma (UL), a benign tumor in women characterized by precise localization. In this study, we investigate the efficiency of αvβ3 integrin-targeted argini…

2020
Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells.
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph13100300

Efficient and specific delivery of nucleic acid (NA) therapeutics to tumor cells is extremely important for cancer gene therapy. Various therapeutic strategies include delivery of DNA-therapeutics such as immunostimulatory or suicide genes …

2014
Genetic pass as a background of predictive, preventive, personalized medicine options and limitations
The EPMA journal ·doi:10.1186/1878-5085-5-s1-a54
article 1997
Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population
Molecular human reproduction ·doi:10.1093/molehr/3.9.775

Endometriosis is a multifactorial disease with possible genetic predisposition and involvement of environmental factors in its pathogenesis. The genetic polymorphism of glutathione S-transferase M1 (GSTM1) gene, which codes for glutathione …